Stage | Stage according to CXR (n) | Stage according to HRCT (n) | Consistent cases (n) | Consistency rate (%) | |||
---|---|---|---|---|---|---|---|
I | II | III | IV | ||||
Total, nā=ā227 | |||||||
Ā 0 | 16 | 2 | 11 | 3 | 0 | 0 | 0.0 |
Ā I | 70 | 8 | 62 | 0 | 0 | 8 | 11.4 |
Ā II | 67 | 0 | 62 | 0 | 5 | 62 | 92.5 |
Ā III | 36 | 0 | 23 | 6 | 7 | 6 | 16.7 |
Ā IV | 38 | 0 | 0 | 0 | 38 | 38 | 100.0 |
Ā Total | 227 | 10 | 158 | 9 | 52 | 114 | 50.2 |
Chinese patients, nā=ā140 | |||||||
Ā 0 | 9 | 2 | 7 | 0 | 0 | 0 | 0.0 |
Ā I | 54 | 6 | 48 | 0 | 0 | 6 | 11.1 |
Ā II | 56 | 0 | 56 | 0 | 0 | 56 | 100.0 |
Ā III | 19 | 0 | 15 | 2 | 2 | 2 | 10.5 |
Ā IV | 2 | 0 | 0 | 0 | 2 | 2 | 100.0 |
Ā Total | 140 | 8 | 126 | 2 | 4 | 66 | 47.1 |
American patients, nā=ā87 | |||||||
Ā 0 | 7 | 0 | 4 | 3 | 0 | 0 | 0.0 |
Ā I | 16 | 2 | 14 | 0 | 0 | 2 | 12.5 |
Ā II | 11 | 0 | 6 | 0 | 5 | 6 | 54.5 |
Ā III | 17 | 0 | 8 | 4 | 5 | 4 | 23.5 |
Ā IV | 36 | 0 | 0 | 0 | 36 | 36 | 100.0 |
Ā Total | 87 | 2 | 32 | 7 | 46 | 48 | 55.2 |